Vector: a market access and development company

market access

and development company

Dear colleagues, Once there comes a time, when you realize, that your particular knowledge and experience, a quintessence of all your achievements, are able to make something really meaningful. And this is how the story of our company begins. We united professionals in business, international affairs, with legal, medical and educational background from different countries to benefit from the synergy of knowledge and to ensure the access to innovative health technologies in Eastern Europe. Building a bridge between patients, governments, businesses and professional communities we maintain a sustainable development of healthcare market. Collaborating with European Union, Council of Europe and experts from different European institutions, Vector implements the most progressive market access and market development mechanisms. And you’ll find different examples of unprecedented and invincible actions in this presentation. However, we believe, that the most important challenges are still in our future. And I look forward to build successful working relationship with the best manufacturers and distributors of ethical, and patient-oriented health technologies here. Those, interested to share the fundamental European values. With best regards,

Eugeny Nayshtetik MIB, MM, MSoc CEO and co-founder of Vector Ltd

MODERN

DYNAMIC PROFESSIONAL

EUROPEAN INVINCIBLE

CREATIVE

4

Key Ac'vity Areas

PhE and Epi studies Localization of international outcome researches Expert networking and KOL management

Expert Data Research Market access consulting

Licensing and TT Intellectual property rights protection

Business Development

Expert network development Advocacy and awareness raising campaigns CoE Complaint Mechanism Moderation of civic society institutions

Building Competencies International law monitoring

Cross governmental policy adoption Public-private partnership

Framework agreements

Public Affairs

Suppor'ng sustainable development of your business

5

Coopera'on Time Flow

Confidentiality Note

Incoming cooperation proposal

from client

Concept Plan

Signing an Agreement

Specification and Adoption

Invoicing Commercial Annex to the Agreement

Ongoing information support

Market Research

Evaluation Concept Plan Implementation

Final Plan Completion Report


Facilitate an access to state-of-the-art healthcare technologies

to ensure the fundamental human rights fulfillment

Our Mission

Our Vision

To be reliable and the most confident supplier of market access and market development tools in

Eastern European healthcare systems

Main Values

Life Human Rights

Rule of Law Sustainable Development

Self Policing and Ethics Our activity corresponds and is guided by:

ü  IFPMA Code of Practice1

ü  Criminal Law Convention on Corruption2

ü  Civil Law Convention on Corruption3

ü  Ukrainian Act on the Prevention and Combating of

Corruption4

ü  US Foreign Corrupt Practices Act (FCPA)5

ü  UK Bribery Act 20106

1 hDp://www.ifpma.org/ethics/ifpma-‐code-‐of-‐prac'ce/ifpma-‐code-‐of-‐prac'ce.html 2 hDp://conven'ons.coe.int/Treaty/en/Trea'es/Html/173.htm

3 hDp://conven'ons.coe.int/Treaty/en/Trea'es/Html/174.htm

4 hDp://zakon4.rada.gov.ua/laws/show/3206-‐17 5 hDp://www.jus'ce.gov/criminal/fraud/fcpa/ 6 hDp://www.legisla'on.gov.uk/ukpga/2010/23/contents

portfolio of our achievements

Success Stories

Tuberculosis

Campaign on awareness7,8,9:

ü  number of patients increased on 25%

ü  adherence to treatment increased on 30%

ü  preventive measures have been implemented

Campaign period 2001-‐2007

Market Development Project

7 hDp://tb.org.ua/about.html 8 hDp://www.path.org/projects/tuberculosis_control_in_ukraine_ataglance.php 9 hDp://wwwnc.cdc.gov/eid/ar'cle/12/5/05-‐1103_ar'cle.htm

Gaucher Disease

The most fast-tracking regional program development

in Ukraine with further inclusion into the municipal

budget10:

ü  1 patient has got a treatment in 4 month from the

primary stage only

ü  implementation process optimization for International

Cerezyme Access Program in Ukraine

Campaign period 2008-‐2009

Market Development Program

10 Decision of Kharkiv Oblast Council №1076-‐V from 29.01.2009

HIV/AIDS

Campaign on market access 11:

ü  Atripla - was included into National HIV program after

market authorization in 2 months

ü  Isentress - was included into National HIV program after

market authorization in 12 months

ü  Voluntary license on Stocrin (efavirenz) – negotiation

process with local manufacturer was successfully

completed

Campaign period 2010

Market Access Project

11 hDp://zakon4.rada.gov.ua/laws/show/1026-‐17

Vaccina'on

Campaign on market access 12:

ü  Gardasil - was included into National Immunization Plan

as a vaccine recommended in 12 months


Market Access Project

ü  Prevenar - 7/13 were included into National Immunization Plan as a vaccine recommended in 4 months

12 hDp://zakon4.rada.gov.ua/laws/show/z1159-‐11

Interna'onal Affairs and

GR Campaigns


Comments on RAP/Rcha/UKR/5 This unprecedented project is an attempt to expand

healthcare budget of Ukraine through obligations deriving

from the European Social Charter

The world’s first comment13 on national report on

implementation of the article 11 of the European Social

Charter gave evidence in 3 therapeutic areas :

ü  Vaccination

ü  Haemophilia

ü  Hepatitis C

13 www.coe.int/t/dghl/monitoring/socialcharter/Repor'ng/StateReports/CommentsAllUkrainianCouncil2013_en.pdf


WriDen Declara'on #544 Due to our campaign the first European document, calling the budget reallocation to ensure the fulfillment of human rights in Ukrainian health care system, was assigned: by ‘celebrities’ of European political elite:

ü  Jim Dobbin ü  Alexander Scrymgeour (The Earl of DUNDEE) ü  John Prescott ü  Viola von Cramon-Taubadel

by the representatives of: ü  11 National Delegations ü  All European political groups ü  10 Committees (of 11) and 12 Sub-committees

(of 20) 14 hDp://assembly.coe.int/ASP/Doc/XrefDocDetails_E.asp?FileID=19932

40-g Frunze St., 3rd entrance, 2nd floor,

Kyiv, 04080, Ukraine +380 50 444 82 74

E-mail: [email protected]


Vector: a market access and development company

Business

Transcript of Vector: a market access and development company